Education & Training
- BA. Tech Biotechnology, Federal University of Technology Akure, Ondo State, Nigeria.
Chukwuemeka, P. O., Umar, H. I., Iwaloye, O., Oretade, O. M., Olowosoke, C. B., Elabiyi, M. O., Igbe, F. O., Oretade, O. J., Eigbe, J. O., & Adeojo, F. J. (2021). Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2021.1924267.
Chukwuemeka, P. O., Umar, H. I., Iwaloye, O., Oretade, O. M., Olowosoke, C. B., Oretade, O. J., & Elabiyi, M. O. (2021). Predictive hybrid paradigm for cytotoxic activity of 1, 3, 4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2021.1913231
Chukwuemeka, P. O., Umar, H. I., Olukunle, O. F., Oretade, O. M., Olowosoke, C. B., Akinsola, E. O., Elabiyi, M. O., Kurmi, U. G., Eigbe, J. O., Oyelere, B. R., Isunu, L. E., & Oretade, O. J. (2020). In Silico design and validation of a highly degenerate primer pair: a systematic approach. Journal of Genetic Engineering and Biotechnology, 18, 72. https://doi.org/10.1186/s43141-020-00086-y
Elekofehinti, O. O., Iwaloye, O., Olawale, F., Chukwuemeka, P. O., & Folorunso, I. M. (2021). Newly designed compounds from scaffolds of known actives as inhibitors of surviving: computational analysis from the perspective of fragment-based drug design. In Silico Pharmacology, 9, 47. https://doi.org/10.1007/s40203-021-00108-8